2016 updated EULAR evidence-based recommendations for the management of gout

P Richette, M Doherty, E Pascual, V Barskova… - Annals of the …, 2017 - ard.bmj.com
Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

[HTML][HTML] Gout: An old disease in new perspective–A review

G Ragab, M Elshahaly, T Bardin - Journal of advanced research, 2017 - Elsevier
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood
and described type of arthritis. Its epidemiology is studied. New insights into the …

[HTML][HTML] The British Society for Rheumatology guideline for the management of gout

M Hui, A Carr, S Cameron, G Davenport… - …, 2017 - academic.oup.com
Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …

[HTML][HTML] Physiology of hyperuricemia and urate-lowering treatments

CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …

D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …

Safety and tolerability of available urate-lowering drugs: a critical review

L Strilchuk, F Fogacci, AF Cicero - Expert Opinion on Drug Safety, 2019 - Taylor & Francis
Introduction: Urate-lowering therapy (ULT) is the cornerstone of gout management, which is
a widespread chronic illness characterized by hyperuricemia, arthropathy, tophus …

Hyperuricemia and cardiovascular disease

S Zhang, Y Wang, J Cheng, N Huangfu… - Current …, 2019 - ingentaconnect.com
Purine metabolism in the circulatory system yields uric acid as its final oxidation product,
which is believed to be linked to the development of gout and kidney stones. Hyperuricemia …

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad …

F Sivera, M Andrés, L Carmona, ASR Kydd… - Annals of the …, 2014 - ard.bmj.com
We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …

Pathogenesis of acute stroke and the role of inflammasomes

DYW Fann, SY Lee, S Manzanero, P Chunduri… - Ageing research …, 2013 - Elsevier
Inflammation is an innate immune response to infection or tissue damage that is designed to
limit harm to the host, but contributes significantly to ischemic brain injury following stroke …

Pyroptotic neuronal cell death mediated by the AIM2 inflammasome

SE Adamczak, JP de Rivero Vaccari… - Journal of Cerebral …, 2014 - journals.sagepub.com
The central nervous system (CNS) is an active participant in the innate immune response to
infection and injury. In these studies, we show embryonic cortical neurons express a …